rs753442959
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_001378609.3(OTOGL):c.4860G>A(p.Lys1620Lys) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.0000263 in 1,561,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001378609.3 splice_region, synonymous
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 84BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OTOGL | NM_001378609.3 | c.4860G>A | p.Lys1620Lys | splice_region_variant, synonymous_variant | Exon 42 of 59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| OTOGL | ENST00000547103.7 | c.4860G>A | p.Lys1620Lys | splice_region_variant, synonymous_variant | Exon 42 of 59 | 5 | NM_001378609.3 | ENSP00000447211.2 | ||
| OTOGL | ENST00000646859.1 | c.4725G>A | p.Lys1575Lys | splice_region_variant, synonymous_variant | Exon 46 of 63 | ENSP00000496036.1 | ||||
| OTOGL | ENST00000298820.7 | c.159G>A | p.Lys53Lys | splice_region_variant, synonymous_variant | Exon 3 of 18 | 5 | ENSP00000298820.3 |
Frequencies
GnomAD3 genomes AF: 0.0000463 AC: 7AN: 151294Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000436 AC: 8AN: 183400 AF XY: 0.0000614 show subpopulations
GnomAD4 exome AF: 0.0000241 AC: 34AN: 1410206Hom.: 0 Cov.: 31 AF XY: 0.0000258 AC XY: 18AN XY: 697830 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000463 AC: 7AN: 151294Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73844 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Lys1611Lys variant in OTOGL has been identified in cis with the p.Phe845Leu variant in one individual with hearing loss by our laboratory and has been reported together with p.Phe845Leu in one additional individual with hearing loss (phase unknown; Zazo Seco 2017). The p.Lys1611Lys variant has also been identified in 0.008% (8/90266) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org), and has been reported as a variant of uncertain significance in ClinVar (Variation ID 425014). This variant is located in the last base of the exon, which is part of the 5’ splice region. While computational tools do not suggest an impact to splicing, this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Lys1611Lys variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, BP4. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at